Menu

Benchmark Reiterates Buy on OmniAb, Maintains $8 Price Target

Benzinga Newsdesk 1 year ago

NewsPrice TargetReiterationAnalyst Ratings

Benchmark analyst Robert Wasserman reiterates OmniAb (NASDAQ:OABI) with a Buy and maintains $8 price target.

Benchmark analyst Robert Wasserman reiterates OmniAb (NASDAQ:OABI) with a Buy and maintains $8 price target.

Read the original